Effects of Lactobacillus paracasei 01 fermented milk beverage on protection of intestinal epithelial cell in vitro

Journal of the Science of Food and Agriculture

Volumn 96, Issue 6, 2016, Pages 2154-2160

  Chen, Yen Po ^a   Hsu, Chih An ^b   Hung, Wei Ting ^c   Chen, Ming Ju ^c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b Weichuan Central Research and Development Institute   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Fermented milk beverage; Intestinal epithelial cell; Intestine protection; Lactobacillus paracasei

Indexed keywords

CACO-2 CELL LINE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; FERMENTED MILK PRODUCT; HUMAN; INTESTINE MUCOSA; LACTOBACILLUS PARACASEI; METABOLISM; MICROBIOLOGY;

CACO-2 CELLS; CELLS, CULTURED; CULTURED MILK PRODUCTS; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; LACTOBACILLUS PARACASEI;

EID: 84960237135     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.7331     Document Type: Article

References (41)

1. Khani S, Hosseini HM, Taheri M, Nourani MR and Fooladi AAI, Probiotics as an alternative strategy for prevention and treatment of human disease: a review. Inflam Allergy Drug Targets 11:79-89 (2012).
2. Ohland CL and MacNaughton WK, Probiotic bacteria and intestinal epithelial function. Am J Physiol Gastrointest Liver Physiol 298:G807-G819 (2010).
3. Fontana L, Bermudez-Brito M, Plaza-Díaz J, Munoz-Quezada S and Gil A, Sources, isolation, characterization and evaluation of probiotics. Br J Nutr 109:S35-S50 (2013).
4. Wassenberg J, Nutten S, Audran R, Barbier N, Aubert V, Moulin J et al., Effects of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clin Exp Immunol 41:565-573 (2011).
5. Chiang SS and Pan TM, Beneficial effects of Lactobacillus paracasei subsp. paracasei NTU 101 and its fermented products. Appl Microbiol Biotechnol 93:903-916 (2012).
6. Pellaton C, Nutten S, Thierry A, Boudousquie C, Barbier N, Blanchard C et al., Intragastric and intranasal administration of Lactobacillus paracasei NCC2461 modulates allergic airway inflammation in mice. Int J Inflammation, article ID: 686739 (2012).
7. Mileti E, Matteoli G, Iliev LD and Rescigno M, Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS ONE 4:e7056 (2009).
8. Bermudez-Brito M, Munoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, Romero F et al., Human intestinal dendritic cells decrease cytokine release against Salmonella infection in the presence of Lactobacillus paracasei upon TLR activation. PLoS ONE 7:e43197 (2012).
9. Tsai YT, Cheng PC, Liao J and Pan TM, Effects of administration of Lactobacillus paracasei subsp. paracasei NTU 101 on Peyer's patch-mediated mucosal immunity. Int Immunopharmacol 10:791-798 (2010).
10. Oliveira M, Bosco N, Perruisseau G, Nicolas J, Segura-Roggero I, Duboux S et al., Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis. Clin Dev Immunol, article ID: 807483 (2011).
11. Thoreux K, Senegas-Balas F, Bernard-Perrone F, Giannarelli S, Denariaz G, Bouley C et al., Modulation of proliferation, second messenger levels, and morphotype expression of the rat intestinal epithelial cell line IEC-6 by fermented milk. J Dairy Sci 79:33-43 (1996).
12. Zagato E, Mileti E, Massimiliano L, Fasano F, Budelli A, Penna G et al., Lactobacillus paracasei CBA L74 metabolic products and fermented milk for infant formula have anti-inflammatory activity on dendritic cells in vitro and protective effects against colitis and an enteric pathogen in vivo. PLoS ONE 9:e87615 (2014).
13. Artis D, Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8:411-420 (2008).
14. Mitic LL and Anderson JM, Molecular architecture of tight junctions. Annu Rev Physiol 60:121-142 (1998).
15. Turner JR, Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9:799-809 (2009).
16. Klingberg TD, Pedersen MH, Cencič A and Budde BB, Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Appl Environ Microbiol 71:7528-7532 (2005).
17. Li N, DeMarco VG, West CM and Neu J, Glutamine supports recovery from loss of transepithelial resistance and increase of permeability induced by media change in Caco-2 cells. J Nutr Biochem 14:401-408 (2003).
18. Chen YP, Hsiao PJ, Hong WS, Dai TY and Chen MJ, Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vivo. J Dairy Sci 95:63-74 (2012).
19. Reilly N, Poylin V, Menconi M, Onderdonk A, Bengmark S and Hasselgren P, Probiotics potentiate IL-6 production in IL-1β-treated Caco-2 cells through a heat shock-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 293:R1169-R1179 (2007).
20. Bendali F, Madi N and Sadoun D, Beneficial effects of a strain of Lactobacillus paracsei subsp. paracsei in Staphylococcus aureus-induced intestinal and colonic injury. Int J Infect Dis 15:e787-e794 (2011).
21. Resta-Lenert S and Barrett KE, Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130:731-746 (2006).
22. Kaser A, Ludwiczek O, Holzmann S, Moschen AR, Weiss G, Enrich B et al., Increased expression of CCL20 in human inflammatory bowel disease. J Clin Immunol 24:74-85 (2004).
23. Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N et al., Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204:2803-2012 (2007).
24. Sibartie S, O'Hara AM, Ryan J, Fanning Á, O'Mahony J, O'Neill S et al., Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria. BMC Immunol 10:54 (2009).
25. Toki S, Kagaya S, Shinohara M, Wakiguchi H, Matsumoto T, Takahata Y et al., Lactobacillus rhamnosus GG and Lactobacillus casei suppress Escherichia coli-induced chemokine expression in intestinal epithelial cells. Int Arch Allergy Immunol 148:45-58 (2009).
26. Romanin D, Serradell M, Maciel DG, Lausada N, Garrote GL and Rumbo M, Down-regulation of intestinal epithelial innate response by probiotic yeasts isolated from kefir. Int J Food Microbiol 140:102-108 (2010).
27. Vongsa RA, Zimmerman NP and Dwinell MB, CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells. J Biol Chem 284:10034-10045 (2009).
28. Agle KA, Vongsa RA and Dwinell MB, Calcium mobilization triggered by the chemokine CXCL12 regulates migration in wounded intestinal epithelial monolayers. J Biol Chem 285:16066-16075 (2010).
29. Anderson RC, Cookson AL, McNabb WC, Kelly WJ and Roy NC, Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiol Lett 309:184-192 (2010).
30. Karczewiski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJM et al., Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 298:G851-G859 (2010).
31. Resta-Lenert S and Barrett KE, Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52:988-997 (2003).
32. Sherman PM, Johnson-Henry KC, Yeung HP, Ngo PSC, Goulet J and Tompkins TA, Probiotics reduce enterohemorrhagic Escherichia coli O157:H7 and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monloayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 73:5183-5188 (2005).
33. Fajdiga S, Koninkx JFJG, Tooten PCJ and Marnšek-Logar R, Interference of Salmonella enteritidis and Lactobacillus spp. with IL-8 levels and transepithelial electrical resistance of enterocyte-like Caco-2 cells. Folia Microbiol (Praha) 51:268-272 (2006).
34. Zyrek AA, Cichon C, Helms S, Enders C, Sonnenborn U and Schmidt A, Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 9:804-816 (2007).
35. Otte JM, Cario E and Podolsky DK, Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126:1054-1070 (2004).
36. Cario E, Gerken G and Podolsky DK, Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127:224-238 (2004).
37. Cario E, Gerken G and Podolsky DK, Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132:1359-1374 (2007).
38. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S and Medzhitov R, Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118:229-241 (2004).
39. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B et al., Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenternology 126:520-528 (2004).
40. Nyangale EP, Mottram DS and Gibson GR, Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res 11:5573-5585 (2012).
41. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H et al., Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40:128-139 (2014).